Symbol: |
MED16
|
Description: |
mediator complex subunit 16 [Source:HGNC Symbol;Acc:17556]
|
Location: |
Chr19:867964-893218[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:154
Gene |
Compound |
Gen_sig |
Exp_pattern |
MED16 |
Phenol, 4-(5,6-dimethyl-1H-benzimidazol-2-yl)- 2,6-bis(1,1-dimethylethyl)- |
0.041 |
Down |
MED16 |
NSC 716543 |
0.021 |
Down |
MED16 |
NSC 718025 |
0.005 |
Down |
MED16 |
NSC 718209 |
0.043 |
Down |
MED16 |
NSC 718630 |
0.044 |
Down |
MED16 |
NSC 718652 |
0.022 |
Down |
MED16 |
NSC 718661 |
0.039 |
Up |
MED16 |
NSC 719485 |
0.003 |
Down |
MED16 |
1-O-Octadecyl-[(2.fwdarw.5')-3'-C-ethinyl-cytidylyl]-rac-glycerylyl-(3.fwdarw.5')-5-fluoro-2'-deoxyuridine |
0.023 |
Down |
MED16 |
5-(p-chlorobenzylidene)-3-phenyl-2-[(1-phenyl-3,5- dimethylpyrazol-4-yl)methylidenehydrazono]thiazolidin-4-one |
0.041 |
Down |
MED16 |
N-(6'-Chrysenyl)-4-(1'-piperidinyl)-D-2,3-dioxalono-butane-1 ,4-dicarboximide |
0.021 |
Down |
MED16 |
3'-C-ethinylcytidine |
0.016 |
Down |
MED16 |
NSC 724771 |
0.013 |
Down |
MED16 |
(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-9-methylene-11,14,15,16-t etraoxatetracyclo[10.3.1.04,13.08,13]hexadec-10-yl]oxy}-3-he xenyl)oxy]-1,5,-dimethyl-9-methylene-11,14,15,16-tetraoxatet racyclo[10.3.1.04,13.08,13]hexadecane |
0.002 |
Down |
MED16 |
Bis-{(5,6-dihydro-5,11-diketo-11H-indeno[1,2-c]isoquinoline) -6-propylamino}ethane Bis(trifluoroacetate |
0.013 |
Down |
Expression pattern: Sensitivity / Resistance
Total:11 Current:9
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:10
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:null
Gene |
Gen_transcript |
miRNA |
miR_location |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|